PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

Name: PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Published: 2024
License: Public Domain

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

esophageal-squamous-cell-carcinoma

esophageal squamous cell carcinoma, ypt1-4n0m0, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

Related documents